Tuberculosis News and Research

Latest Tuberculosis News and Research

Host immune system forms small lesions in the intestines in response to bacterial infection

Yersinia bacteria cause a variety of human and animal diseases, the most notorious being the plague, caused by Yersinia pestis.

14 Mar 2023

Wayne State team discovers a simple technology to detect active TB infection antibodies

A team of faculty from Wayne State University has discovered new technology that will quickly and easily detect active Mycobacterium tuberculosis (TB) infection antibodies.

13 Mar 2023

New community-based diagnostic tool is feasible and effective for diagnosing tuberculosis

A new, low-cost, scalable package for diagnosing tuberculosis (TB) onsite in resource-poor community settings is feasible and effective, according to a new trial.

10 Mar 2023

Low-cost smart textile sensor could help tackle the spread of tuberculosis in Asia and Africa

Scientists are developing a low-cost smart textile sensor for early detection of tuberculosis in people and cattle which they hope will help tackle the spread of the disease in Asia and Africa.

9 Mar 2023

Study identifies genetic variants influencing human fertility

Fertility is influenced by mechanisms that influence both reproductive biology and human behavior, according to the largest study to date identifying genetic determinants of the number of children an individual may have.

6 Mar 2023

Clinical trial shows safety and immunogenicity of temperature-stable experimental TB vaccine

A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found that it was safe and stimulated both antibodies and responses from the cellular arm of the immune system.

6 Mar 2023

Proactive case-finding strategies should be expanded for earlier treatment of tuberculosis

From a global perspective, tuberculosis is a common disease. It is often associated with poverty-related living conditions and more common in low-income countries. In Germany, the disease is rare, with 4.7 new cases per 100,000 inhabitants.

6 Mar 2023

BioInfect: Bringing the best brains to the challenge of antimicrobial resistance

During the conference, we had the chance to catch up with some of the speakers to ask them about their work, as well as what they would be discussing at the 2023 BioInfet Conference.

6 Mar 2023

Innovative method to spot bacteria in blood, wastewater, and more

Shine a laser on a drop of blood, mucus, or wastewater, and the light reflecting back can be used to positively identify bacteria in the sample.

3 Mar 2023

How did people in Zimbabwe respond to drug-resistant tuberculosis alongside COVID-19?

In a recent study posted to the medRxiv* preprint server, researchers described the experiences and coping strategies of people who suffered from drug-resistant tuberculosis (DR-TB) in Zimbabwe between 2020 and 2021.

1 Mar 2023

Study explores the epidemiological characteristics of pulmonary tuberculosis in patients with pneumoconiosis

Pneumoconiosis comprises a group of heterogeneous lung diseases resulting from the inhalation of mineral dust. It is an occupational hazard with significant economic and social implications.

1 Mar 2023

The rapid diagnosis of drug-resistant and drug-sensitive tuberculosis using mass spectrometry and machine learning

In a recent study posted to the Preprints with The Lancet SSRN* server, a team of researchers in China developed a machine learning-based diagnostic tool to detect tuberculosis and drug-resistant tuberculosis using nanoparticle-enhanced laser desorption/ionization mass spectrometry (NPELDI MS) to determine metabolic fingerprints from serum samples.

28 Feb 2023

St. Jude researchers show how drug makers can avoid toxicity and resistance

Scientists at St. Jude Children's Research Hospital have demonstrated how drug makers can avoid two key problems: toxicity and resistance.

28 Feb 2023

New solutions to boost Africa’s vaccine production

The COVID-19 pandemic has highlighted the importance of vaccines in controlling infectious disease in sub-Saharan Africa and renewed interest in vaccine research and development across the continent.

28 Feb 2023

Study finds unique epigenetic biosignature in individuals with post-COVID syndrome

A reprogramming of which genes are active, and which are not, is visible in post-COVID sufferers. This is shown in a study from Linköping University, Sweden, on a small group of individuals.

28 Feb 2023

New method to measure drugs and lipids in cells could lead to effective treatments for diseases

A new state-of-the-art method that measures the amounts of drugs and lipids (fats) in individual cells could help health professionals target more effective treatments for diseases such as tuberculosis (TB).

17 Feb 2023

As covid grabbed the world’s attention, Texas’ efforts to control TB slipped

Narciso Lopez has spent more than two decades working to control the spread of tuberculosis in South Texas.

16 Feb 2023

Study highlights the interconnectedness of autoimmunity and cancer

In a recent study published in the journal Immunity, researchers reviewed the T cell response in cancer and autoimmunity to propose strategies for more effective immunotherapies.

15 Feb 2023

The impact of COVID-19 on consultations and antibiotic prescribing for URTI in England

In a recent study published in the journal JAC-Antimicrobial Resistance, researchers investigated the trends in antibiotic prescriptions for upper respiratory tract infections to determine whether the decrease in in-person medical consultation appointments during the coronavirus disease 2019 (COVID-19) pandemic had an impact on the prescribing practices.

15 Feb 2023

"AutoPLP" technique enables rapid, accurate detection of mutating bacteria and viruses

As we now know from our experience with the COVID-19 pandemic, the microbes responsible for some infections can rapidly mutate into variants that evade detection and treatment.

15 Feb 2023

Tuberculosis News and Research

Latest Tuberculosis News and Research

Host immune system forms small lesions in the intestines in response to bacterial infection

Wayne State team discovers a simple technology to detect active TB infection antibodies

New community-based diagnostic tool is feasible and effective for diagnosing tuberculosis

Low-cost smart textile sensor could help tackle the spread of tuberculosis in Asia and Africa

Study identifies genetic variants influencing human fertility

Clinical trial shows safety and immunogenicity of temperature-stable experimental TB vaccine

Proactive case-finding strategies should be expanded for earlier treatment of tuberculosis

BioInfect: Bringing the best brains to the challenge of antimicrobial resistance

Innovative method to spot bacteria in blood, wastewater, and more

How did people in Zimbabwe respond to drug-resistant tuberculosis alongside COVID-19?

Study explores the epidemiological characteristics of pulmonary tuberculosis in patients with pneumoconiosis

The rapid diagnosis of drug-resistant and drug-sensitive tuberculosis using mass spectrometry and machine learning

St. Jude researchers show how drug makers can avoid toxicity and resistance

New solutions to boost Africa’s vaccine production

Study finds unique epigenetic biosignature in individuals with post-COVID syndrome

New method to measure drugs and lipids in cells could lead to effective treatments for diseases

As covid grabbed the world’s attention, Texas’ efforts to control TB slipped

Study highlights the interconnectedness of autoimmunity and cancer

The impact of COVID-19 on consultations and antibiotic prescribing for URTI in England

"AutoPLP" technique enables rapid, accurate detection of mutating bacteria and viruses

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Tuberculosis News and Research

Latest Tuberculosis News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in